{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T20:29:45Z","timestamp":1722198585652},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.thromres.2011.07.032","type":"journal-article","created":{"date-parts":[[2011,8,18]],"date-time":"2011-08-18T05:11:53Z","timestamp":1313644313000},"page":"459-464","source":"Crossref","is-referenced-by-count":6,"title":["Haplotypes of the endothelial protein C receptor gene and Beh\u00e7et's disease"],"prefix":"10.1016","volume":"129","author":[{"given":"Silvia","family":"Navarro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Bonet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Martos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Ricart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amparo","family":"Vay\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Todol\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Fontcuberta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amparo","family":"Estell\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Espa\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2011.07.032_bb0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0049-0172(98)80001-2","article-title":"Beh\u00e7et disease","volume":"27","author":"Kaklamani","year":"1998","journal-title":"Semin Arthritis Rheumatol"},{"key":"10.1016\/j.thromres.2011.07.032_bb0010","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u00e7et's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2011.07.032_bb0015","first-page":"402","article-title":"Vascular involvement in Beh\u00e7et's disease","volume":"19","author":"Ko\u00e7","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.thromres.2011.07.032_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9343(01)01048-8","article-title":"Vascular involvement in Beh\u00e7et's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin","volume":"112","author":"Espinosa","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.thromres.2011.07.032_bb0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0049-3848(02)00006-3","article-title":"Pathological haemostasis and \"prothrombotic state\" in Beh\u00e7et's disease","volume":"105","author":"Kiraz","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2011.07.032_bb0030","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.thromres.2006.02.008","article-title":"Decreased nitric oxide and increased platelet aggregation levels in patients with Beh\u00e7et's disease","volume":"119","author":"Yapi\u015flar","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2011.07.032_bb0035","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/rheumatology\/38.12.1298","article-title":"Procoagulant mutations and venous thrombosis in Beh\u00e7et's disease","volume":"38","author":"G\u00fcl","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.thromres.2011.07.032_bb0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0049-3848(02)00085-3","article-title":"Coagulation parameters and plasma total homocysteine levels in Beh\u00e7et's disease","volume":"106","author":"Lee","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2011.07.032_bb0045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.thromres.2010.05.019","article-title":"The plasma levels of activated thrombin activatable fibrinolysis inhibitor and thrombomodulin in Beh\u00e7et disease and their association with thrombosis","volume":"126","author":"Donmez","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2011.07.032_bb0050","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2141.2004.05072.x","article-title":"Activated protein C levels in Beh\u00e7et's disease and risk of venous thrombosis","volume":"126","author":"Navarro","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2011.07.032_bb0055","first-page":"496","article-title":"Beh\u00e7et disease: study of 74 patients","volume":"127","author":"Ricart","year":"2006","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.thromres.2011.07.032_bb0060","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1365-2141.2008.07078.x","article-title":"Fibrinolytic inhibitor levels and polymorphisms in Beh\u00e7et disease and their association with thrombosis","volume":"141","author":"Ricart","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2011.07.032_bb0065","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/112067210801800410","article-title":"Ocular inflammatory signs observed in a cohort of Spanish patients with Beh\u00e7et disease and ocular inflammation","volume":"18","author":"S\u00e1enz-Franc\u00e9s","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.thromres.2011.07.032_bb0070","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.semarthrit.2010.05.008","article-title":"Systematic Review on the Effectiveness of Immunosuppressants and Biological Therapies in the Treatment of Autoimmune Posterior Uveitis","volume":"40","author":"Pato","year":"2011","journal-title":"Semin Arthritis Rheumatol"},{"key":"10.1016\/j.thromres.2011.07.032_bb0075","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1182\/blood.V78.2.416.416","article-title":"Evidence of activation of the protein C pathway during acute vascular damage induced by Mediterranean spotted fever","volume":"78","author":"Vicente","year":"1991","journal-title":"Blood"},{"issue":"Suppl 2","key":"10.1016\/j.thromres.2011.07.032_bb0080","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0049-3848(10)70153-5","article-title":"Inflammation and coagulation","volume":"127","author":"Pet\u00e4j\u00e4","year":"2011","journal-title":"An overview. Thromb Res"},{"key":"10.1016\/j.thromres.2011.07.032_bb0085","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1055\/s-0037-1616737","article-title":"Low level of circulating activated protein C is a risk factor for venous thrombosis","volume":"86","author":"Espa\u00f1a","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.07.032_bb0090","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/j.1538-7836.2006.01996.x","article-title":"Circulating activated protein C is reduced in young survivors of myocardial infarction and inversely correlates with the severity of coronary lesions","volume":"4","author":"Zorio","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.07.032_bb0095","doi-asserted-by":"crossref","first-page":"10212","DOI":"10.1073\/pnas.93.19.10212","article-title":"The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex","volume":"93","author":"Stearns-Kurosawa","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"10.1016\/j.thromres.2011.07.032_bb0100","first-page":"34","article-title":"The protein C system (TM EPCR)","volume":"115","author":"Isermann","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2011.07.032_bb0105","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1538-7836.2005.01385.x","article-title":"Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin","volume":"3","author":"Li","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.07.032_bb0110","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1160\/TH09-11-0750","article-title":"Blocking endothelial protein C receptor (EPCR) accelerates thrombus development in vivo","volume":"103","author":"Centelles","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.07.032_bb0115","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1160\/TH07-01-0071","article-title":"Polymorphisms in the endothelial protein C receptor gene and thrombophilia","volume":"98","author":"Medina","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.07.032_bb0120","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1182\/blood-2003-07-2520","article-title":"A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis","volume":"103","author":"Saposnik","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2011.07.032_bb0125","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1160\/TH03-10-0657","article-title":"Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels and thrombotic risk","volume":"91","author":"Medina","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.07.032_bb0130","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1046\/j.1538-7836.2004.00855.x","article-title":"Haplotypes of the EPCR gene plasma sEPCR levels and the risk of deep venous thrombosis","volume":"2","author":"Uitte de Willige","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.07.032_bb0135","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.atherosclerosis.2005.02.028","article-title":"EPCR Ser219Gly: elevated sEPCR prothrombin F1+2 risk for coronary heart disease and increased sEPCR shedding in vitro","volume":"183","author":"Ireland","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2011.07.032_bb0140","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3324\/haematol.12448","article-title":"Haplotypes of the EPCR gene prothrombin levels and the risk of venous thrombosis in carriers of the prothrombin G20210A mutation","volume":"93","author":"Navarro","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2011.07.032_bb0145","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1538-7836.2005.01676.x","article-title":"The Ser219\u2013>Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the H3 haplotype","volume":"4","author":"Qu","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.07.032_bb0150","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3324\/haematol.13066","article-title":"Endothelial protein C receptor polymorphisms and risk of myocardial infarction","volume":"93","author":"Medina","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2011.07.032_bb0155","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1160\/TH07-10-0607","article-title":"Failure to validate association of gene polymorphisms in EPCR PAR-1 FSAP and protein S Tokushima with venous thromboembolism among Californians of European ancestry","volume":"99","author":"Pecheniuk","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.07.032_bb0160","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et's disease","volume":"335","author":"International Study Group for Beh\u00e7et's disease","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2011.07.032_bb0165","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/oxfordjournals.aje.a008713","article-title":"Validated questionnaire for the identification of previous personal or familial venous thromboembolism","volume":"143","author":"Frezzato","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.thromres.2011.07.032_bb0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0038-1650221","article-title":"Quantification of circulating activated protein C in human plasma by immunoassays \u2013 enzyme levels are proportional to total protein C levels","volume":"75","author":"Espa\u00f1a","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.07.032_bb0175","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1182\/blood.V77.8.1754.1754","article-title":"In vivo and in vitro complexes of activated protein C with two inhibitors in baboon","volume":"77","author":"Espa\u00f1a","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2011.07.032_bb0180","first-page":"1180","article-title":"Evaluation of an automated method for the quantification of von Willebrand factor antigen. Its application in the study of vascular dysfunction","volume":"86","author":"Villa","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2011.07.032_bb0185","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0049-3848(86)90023-X","article-title":"Assay of protein C in human plasma: comparison of amidolytic, coagulation and immunochemical assays","volume":"44","author":"Espa\u00f1a","year":"1986","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2011.07.032_bb0190","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0049-3848(89)90298-3","article-title":"Determination of functional and antigen protein C inhibitor and its complexes with activated protein C in plasma by ELISAs","volume":"55","author":"Espa\u00f1a","year":"1989","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2011.07.032_bb0195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00001721-199505000-00008","article-title":"A rapid screening method for the factor V Arg 506 Gln mutation","volume":"6","author":"Gandrille","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2011.07.032_bb0200","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variant in the 3\u2019-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2011.07.032_bb0205","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1160\/TH05-02-0089","article-title":"Influence of the 4600A\/G and 4678G\/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden","volume":"94","author":"Medina","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.07.032_bb0210","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1111\/j.1538-7836.2008.03118.x","article-title":"PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study","volume":"6","author":"Reiner","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.07.032_bb0215","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1182\/blood-2010-05-283739","article-title":"Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study","volume":"116","author":"Tang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2011.07.032_bb0220","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1538-7836.2011.04256.x","article-title":"High levels of protein C are determined by PROCR haplotype 3","volume":"9","author":"Pintao","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.07.032_bb0225","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00417-008-0873-9","article-title":"Soluble endothelial protein C receptor levels in Beh\u00e7et patients with and without ocular involvement","volume":"246","author":"Yal\u00e7inda\u011f","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.thromres.2011.07.032_bb0230","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood-2006-09-003004","article-title":"The cytoprotective protein C pathway","volume":"109","author":"Mosnier","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2011.07.032_bb0235","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.4049\/jimmunol.165.8.4697","article-title":"The soluble endothelial protein C receptor binds to activated neutrophils: involvement of proteinase-3 and CD11b\/CD18","volume":"165","author":"Kurosawa","year":"2000","journal-title":"J Immunol"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481100404X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481100404X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T21:31:31Z","timestamp":1686259891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938481100404X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S004938481100404X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2011.07.032","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}